Nicole Vitullo, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 17,855 shares at $5.32 ($94K) on 2013-03-08, disclosed to the SEC on 2013-03-11.
Scheduled sale ($94k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.22 | 12,701 | $66K | 70.7% |
| 2 | $5.32 | 5,154 | $27K | 29.3% |
| Total | $5.25 avg | 17,855 | $94K | 100% |
| Filing → |
| ESPR | SELL | 2018-01-26 | $1.7M | — | Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |